Resultats de la cerca - Kaye J

OA02.03. Nutrient biomarker patterns and rates of cognitive decline in dementia-free elders per Bowman G, Quinn J, Kaye J, Shannon J

Exploiting Response Surface Methodology to Engineer the Mechanical Properties of Alginate‐based Hydrogels per Alessio Bucciarelli, Chen Zhao, Xue Bai, Rebekah Kay, Ayşe Latif, Kaye J. Williams, Annalisa Tirella

Obtenir text complet

Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo. per Suzanne L Meredith, Jennifer L Bryant, Muhammad Babur, Philip W Riddell, Roya Behrouzi, Kaye J Williams, Anne White

Obtenir text complet

Preclinical dosimetry: exploring the use of small animal phantoms per Emma R. Biglin, Gareth J. Price, Amy L. Chadwick, Adam H. Aitkenhead, Kaye J. Williams, Karen J. Kirkby

Obtenir text complet

A preclinical radiotherapy dosimetry audit using a realistic 3D printed murine phantom per Emma R. Biglin, Adam H. Aitkenhead, Gareth J. Price, Amy L. Chadwick, Elham Santina, Kaye J. Williams, Karen J. Kirkby

Obtenir text complet

Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment per Emma J Searle, Brian A Telfer, Debayan Mukherjee, Duncan M Forster, Barry R Davies, Kaye J Williams, Ian J Stratford, Tim M Illidge

Obtenir text complet

A Novel Mechanism of Ataxia Telangiectasia Mutated Mediated Regulation of Chromatin Remodeling in Hypoxic Conditions per Maria Likhatcheva, Roben G. Gieling, Roben G. Gieling, James A. L. Brown, James A. L. Brown, James A. L. Brown, Constantinos Demonacos, Kaye J. Williams

Obtenir text complet

Preclinical characterisation of changes in cardiac function and circulating biomarkers following differential irradiation of thoracic volumes per Refik Kuburas, Mihaela Ghita-Pettigrew, Gerard M. Walls, Brianna N. Kerr, Kathryn H. Brown, Cecilia Facchi, Alan McWilliam, Marcel van Herk, Kaye J. Williams, Karl T. Butterworth

Obtenir text complet

Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles per Alice Spadea, Annalisa Tirella, Julio Manuel Rios de la Rosa, Enrique Lallana, Manal Mehibel, Brian Telfer, Nicola Tirelli, Margaret Jayne Lawrence, Kaye J. Williams, Ian J. Stratford, Marianne Ashford

Obtenir text complet

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer per Becky A. S. Bibby, Niluja Thiruthaneeswaran, Lingjian Yang, Ronnie R. Pereira, Elisabet More, Darragh G. McArt, Paul O’Reilly, Robert G. Bristow, Kaye J. Williams, Ananya Choudhury, Catharine M. L. West

Obtenir text complet

Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity per Hanan Abumanhal-Masarweh, Salam A. Assi, Xinming Liu, Conrado Guerrero Quiles, Taha Lodhi, Kaye J. Williams, Eleanor J. Cheadle, Kostas Kostarelos, Ananya Choudhury, David C. Wedge, Catharine M. L. West, Marilena Hadjidemetriou

Obtenir text complet

The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy. per Simon J A van Kuijk, Roben G Gieling, Raymon Niemans, Natasja G Lieuwes, Rianne Biemans, Brian A Telfer, Guido R M M Haenen, Ala Yaromina, Philippe Lambin, Ludwig J Dubois, Kaye J Williams

Obtenir text complet

Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas per Airley Rachel E, Williams Kaye J, Ly Lucy, Yin Xiaoke, Mayr Manuel, McSheehy Paul M, Chung Yuen-Li, Troy Helen, Golinska Monika, Harris Adrian L, Latigo John, Perumal Meg, Aboagye Eric O, Perrett David, Stubbs Marion, Griffiths John R

Obtenir text complet

High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma. per Kenny Kwok-Hei Yu, Jessica T Taylor, Omar N Pathmanaban, Amir Saam Youshani, Deniz Beyit, Joanna Dutko-Gwozdz, Roderick Benson, Gareth Griffiths, Ian Peers, Peter Cueppens, Brian A Telfer, Kaye J Williams, Catherine McBain, Ian D Kamaly-Asl, Brian W Bigger

Obtenir text complet

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN)... per Peter Hoskin, Marina Lee, Denise Dunkley, Mary Danh, Robin Wickens, Geoff Saunders, Josh Northey, Simon Crabb, Vicky McFarlane, Azmat Sadozye, Rachel Cooper, Tony Mathew, Kate Haslett, Kim Reeves, Rachel Reed, Kamilla Bigos, Kaye J. Williams, Emily Rowling, Ananya Choudhury, Sonia Dancer, Deb Smith, Gareth Griffiths

Obtenir text complet

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. per Cian M McCrudden, Martin G O'Rourke, Kim E Cherry, Hiu-Fung Yuen, Declan O'Rourke, Muhammad Babur, Brian A Telfer, Huw D Thomas, Patrick Keane, Thiagarajan Nambirajan, Chris Hagan, Joe M O'Sullivan, Chris Shaw, Kaye J Williams, Nicola J Curtin, David G Hirst, Tracy Robson

Obtenir text complet

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models per Chun Wai Wong, Christos Evangelou, Kieran N. Sefton, Rotem Leshem, Wei Zhang, Vishaka Gopalan, Sorayut Chattrakarn, Macarena Lucia Fernandez Carro, Erez Uzuner, Holly Mole, Daniel J. Wilcock, Michael P. Smith, Kleita Sergiou, Brian A. Telfer, Dervla T. Isaac, Chang Liu, Nicholas R. Perl, Kerrie Marie, Paul Lorigan, Kaye J. Williams, Patricia E. Rao, Raghavendar T. Nagaraju, Mario Niepel, Adam F. L. Hurlstone

Obtenir text complet